Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1994264 citationsJournal Article

Authors

Arthur F. Kavanaugh

Laurie S. Davis · The University of Texas Southwestern Medical Center

Lisa Nichols · The University of Texas Southwestern Medical Center

Stephen H. Norris · Boehringer Ingelheim (Germany)

Robert Rothlein · Boehringer Ingelheim (Egypt)

Linda A. Scharschmidt · Boehringer Ingelheim (Taiwan)

P E Lipsky · The University of Texas Southwestern Medical Center

Abstract

Anti-ICAM-1 MAb therapy was well tolerated, resulted in a transient alteration in T lymphocyte recirculation, and effected clinical improvement in some RA patients.

Topics & Keywords

Cell Adhesion Molecules Research Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arthritis & Rheumatism

Volume 37, Issue 7, pp. 992-999

DOI: 10.1002/art.1780370703

Field-Weighted Citation Impact: 7.32